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Background: Hepatitis E virus (HEV) causes an acute viral hepatitis that is transmitted enterically. It is epidemic in
Africa, Asia, the Middle East, and Central America. It is known that HEV can cause extrahepatic manifestations. Here,
we report the first case of acalculous cholecystitis as an extrahepatic symptom of HEV.
Case presentation: A 24-year-old Japanese woman with no notable past medical history presented with
complaints of fever and nausea while she was traveling in Australia; within the previous 2 months, she had also
traveled to India and Africa. She visited a local hospital in Australia, and the laboratory tests showed significantly
elevated levels of transaminase, so she was checked for viral hepatitis. After excluding hepatitis A, B, and C, as well
as other causes of hepatitis, it was revealed that the patient was positive for HEV-IgM. Since she was a visitor to
Australia, she was sent back to Japan and was transferred to our hospital. On day 4, the patient complained of right
upper quadrant pain. Ultrasonography of the abdomen showed a thickened gallbladder wall without calculi.
Acalculous cholecystitis was diagnosed from her course. No antibiotics were administered against it because there
was no evidence of bacterial infection. The edematous wall showed significant improvement on day 11 and had
returned to normal by day 14. The patient was discharged on day 16 because all of the symptoms had disappeared.
Conclusions: We found that HEV can cause acalculous cholecystitis as an extrahepatic manifestation. In addition, the
cholecystitis could be resolved without any antibiotics.
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Hepatitis E virus (HEV) is a non-enveloped, single-
stranded RNA virus that can cause acute hepatitis. There
are four genotypes of HEV: genotypes 1, 2, 3, and 4 [1].
Genotype 1 and 2 are prevalent in the Indian subcontin-
ent, Asia, the Middle East, and Africa [2]. In addition to
the main symptoms of fever, nausea, and jaundice,
several extrahepatic symptoms have also been reported,
including pancreatitis, arthropathy, aplastic anemia, and
Guillain-Barre syndrome [2]. To the best of our know-
ledge, there have been no reported cases of acalculous
cholecystitis as an extrahepatic symptom of HEV.* Correspondence: k-fujioka@rgmc.izumisano.osaka.jp
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A 24-year-old Japanese woman with no notable past
medical history presented with complaints of fever and
nausea while she was traveling in Australia; within the
previous 2 months, she had also traveled to India and
Africa. She visited a local hospital in Australia, and the
laboratory tests showed significantly elevated levels of
transaminase, so she was checked for viral hepatitis.
After excluding hepatitis A, B, and C, as well as other
causes of hepatitis, it was revealed that the patient was
positive for HEV-IgM. Since she was a visitor to
Australia, she was sent back to Japan and was trans-
ferred to our hospital. During her stay in India and
Africa, she ate most of her meals at local restaurants,
and she sometimes drank tap water.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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103/64 mmHg, heart rate of 84 beats/min, and body
temperature of 36.4 °C. Physical examination revealed
jaundice with no tenderness over the right upper
quadrant. The chest, extremities, and other systemic
examinations were unremarkable. Laboratory investi-
gations revealed an aspartate aminotransferase (AST)
level of 1382 U/L, alanine aminotransferase (ALT)
level of 2842 U/L, total bilirubin level of 4.8 mg/dL,
and direct bilirubin level of 3.9 mg/dL. The test re-
sults were all negative for anti-nuclear antibody, anti-
mitochondrial antibody, cytomegalovirus IgG and
IgM, Epstein-Barr virus, and hepatitis A, B, and C
antibodies; but the test for HEV-IgM was positive
(Table 1). Her initial ultrasonography of the abdomen
revealed splenomegaly (108 × 39 mm) and a small
amount of ascites, but no signs of hepatomegaly or
an enlarged gallbladder. According to the data above,
HEV infection was diagnosed.
She was treated with intravenous fluids with normal
saline. On day 4, the patient complained of right upper
quadrant pain. Ultrasonography of the abdomen showed
3 mm of a gallbladder wall; moreover, a physical examin-
ation detected tenderness over the right upper quadrant
and positive Murphy’s sign. Since the levels of trans-
aminase and total bilirubin were gradually declining at
that time, the enlarged gallbladder was left untreated,
but closely followed up. However, the level of AST was
elevated again at 980 U/L on day 7. In addition to the
ultrasonographic findings, perivesical fluid accumulationTable 1 Laboratory data on admission
(Peripheral blood) (Biochemistry) (Viral marker)
WBC 7600/μL TP 5.4 d/dL IgM-HA Ab (−) CMV-IgG (−)
RBC 471 × 104/μL Alb 3.4 g/dL HBs Ag (−) CMV-IgM (−)
Hb 14.3 g/dL BUN 7.4 mg/dL HBs Ab (−) HSV 1 IgG (+)
Hct 41.0 % Cre 0.55 mg/dL HBe Ag (−) HSV 2 IgG (−)
Plt 18.9 × 104/μl T-Bil 4.8 mg/dL Hbe Ab (−) EBV PCR (−)
D-Bil 3.9 mg/dL IgM-HBc Ab (−)
(Coagulation) AST 1382 IU/L HBV DNA (−) (Immunology)
PT 32 % ALT 2842 IU/L HCV Ab (−) ANA (−)
PT-INR 2.07 LDH 555 IU/L HCV RNA (−) Anti-
mitochondrial
Ab (−)
APTT 38.0秒 γ-GTP 103 IU/L
Fib 186.3 mg/dL CHE 148 IU/L
NH3 31 μg/dL Dengue IgG (−)
CRP 1.2 mg/dL Dengue IgM (−)
Na 138 mEq/L HEV-IgG (−)
Cl 101 mEq/L HEV-IgM (+)
K 3.8 mEq/Land an edematous gallbladder wall (4 mm) had appeared
(Fig. 1). There were no stones in the gallbladder. In
addition, there were no other causes of acalculous chole-
cystitis. Pneumonia, acute pancreatitis, hepatic or sub-
phrenic abscess, and right pyelonephritis were
considered for the possible causes but were excluded
from the diagnosis due to the fact that no evidence was
shown on ultrasonographic findings, urinalysis, and
chest X-ray. No antibiotics were administered for the
cholecystitis. From day 9, the levels of transaminase and
bilirubin began to decline even without the use of antibi-
otics. Blood culture was negative, and the procalcitonin
level was within the normal range. Based on these find-
ings, we assessed the cholecystitis was not caused by
bacterial infection and decided not to administer any an-
tibiotics. The edematous wall showed significant im-
provement on day 11 and had returned to normal by
day 14. Since the patient did not complain of abdominal
pain and the findings were gradually being recovered, it
was not necessary to intervene surgically. The patient
was discharged on day 16 because all of the symptoms
had disappeared.
The serum of the patient was tested to identify the
genotype of the HEV at the Osaka Prefectural Institute
of Public Health, and it was identified to be HEV geno-
type 1, OSN2015-5 (Fig. 2). It was confirmed by using
SuperScript III-one step RT-PCR system with Platinum
Taq (Invitrogen).
Discussion
From this case, two important clinical discoveries were
made: (1) HEV can cause acalculous cholecystitis as an
extrahepatic manifestation, and (2) it can recover with-
out any antibiotics.
First, HEV can cause acalculous cholecystitis as an ex-
trahepatic symptom. It has been reported that HEV can
cause pancreatitis, arthropathy, aplastic anemia, and
Guillain-Barre syndrome as extrahepatic symptoms [2,
3]; however, acalculous cholecystitis has not been previ-
ously reported as a symptom of HEV. We performed a
search of the MEDLINE database for the terms ‘chole-
cystitis’ and ‘viral hepatitis E’. Three hits were found, but
the contexts were unrelated to cholecystitis due to HEV.
Hepatitis A virus infection is known to cause acalculous
cholecystitis as a rare complication [4]. Although further
investigations of a larger number of cases are needed to
clarify the matter, it is presumed that hepatitis A virus
invades the endothelial cells of the gallbladder and bile
duct and induces cell-mediated immunity [4, 5]. How-
ever, this is the first case report of acalculous cholecyst-
itis as an extrahepatic manifestation of HEV.
Second, the acalculous cholecystitis due to HEV infec-
tion could recover without any antibiotics. On the sev-
enth day after admission, the level of serum AST was
Fig. 1 Ultrasonography of the gallbladder. Abdominal ultrasonography revealed a gallbladder without calculi, a thickened gallbladder wall
(arrows), and perivesical fluid accumulation. These findings resolved by day 14 after admission
Fig. 2 Phylogenetic tree of HEV. OSN2015-5 HEV is the isolate from the patient (arrow)
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a thickened gallbladder wall without calculi and perivesical
fluid accumulation; these met the criteria for acalculous
cholecystitis [6]. In general, the treatment options for acal-
culous cholecystitis are antibiotics, drainage, and/or oper-
ation. However, none of them were necessary in this case,
and the patient recovered completely. According to the
clinical course, the cholecystitis was secondary to HEV
infection and recovered as the HEV infection resolved.
Humans can be infected by four different genotypes of
HEV: genotypes 1, 2, 3, and 4. HEV genotypes 1 and 2
are common and restricted to human [7]. Individuals
may become infected with HEV genotypes 1 and 2 from
drinking contaminated water, so it was suspected that
this patient became infected with HEV from drinking
tap water in India. Genotype 1 is prevalent in the Indian
subcontinent, Asia, the Middle East, and Africa [2]. The
latent period of HEV infection is approximately 6 to
8 weeks [8]. Based on the travel history of the patient, it
is possible that she became infected with HEV while she
was in India. HEV infection does not affect only devel-
oping countries. HEV genotypes 3 and 4 are found in
some industrialized countries. In addition, zoonotic
transmission to humans is possible with HEV genotypes
3 and 4 [6]. Occasional foodborne outbreaks from the
consumption of undercooked meat contaminated with
HEV have occurred in Europe, North America, Japan,
and New Zealand [9]. Among the different genotypes,
genotype 1 HEV infection can cause the most serious
disease [10]. As such, it is important to determine the
genotype of the HEV infecting a patient to know the
prognosis and to identify the source of the infection.
Conlusion
We found that HEV can cause acalculous cholecystitis as
an extrahepatic manifestation. In addition, the cholecyst-
itis could be resolved without any antibiotics. As such, it
is necessary to check for the presence of cholecystitis by
using abdominal ultrasonography when a patient com-
plains of upper abdominal pain, and laboratory tests
show an elevated level of transaminase. In general, the
treatment options for acute cholecystitis include antibi-
otics and operation; however, if the cholecystitis is
induced by viral hepatitis, none of these options may be
necessary. Further studies are needed to determine how
often HEV infection causes cholecystitis.
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